Heron Therapeutics sees This fall income $40.5M, consensus $39.83M

“We’re inspired by the expansion in This fall 2025, pushed specifically by the momentum in our Acute Care franchise with ZYNRELEF and APONVIE,” stated Craig Collard, CEO. “Along with our income development, we’re extraordinarily happy with the continued progress made throughout all elements of our enterprise all through the previous 12 months.” Preliminary This fall and FY25 Updates: Internet income of roughly $40.5M for the three months ended December 31. ZYNRELEF web income of roughly $12.5M for the three months ended December 31. APONVIE web income of roughly $3.8M for the three months ended December 31. CINVANTI web income of roughly $22.9M for the three months ended December 31. SUSTOL web income of roughly $1.3M for the three months ended December 31. Internet income of roughly $154.9M for FY25. ZYNRELEF delivered the biggest quarter-over-quarter income improve inside the portfolio in This fall.

Revealed first on TheFly – the last word supply for real-time, market-moving breaking monetary information. Strive Now>>

See Insiders’ Sizzling Shares on TipRanks >>

Learn Extra on HRTX:

Disclaimer & DisclosureReport an Challenge